Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Silk Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
Silk Technologies

Silk Technologies

US-based Silk Technologies, Ltd. develops and commercializes silk-derived protein products for ophthalmic use.

HQ
Plymouth, MN, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Silk Technologies, Ltd., founded in Plymouth, United States, is a biotechnology company focused on developing and commercializing silk-derived protein (SDP) products for ophthalmic applications. Their core mission is to create a healthier world through innovative, safe, and effective silk-based ingredients. The company leverages a proprietary database and patented technology to expedite product development, offering solutions that enhance and protect various products with their SDP ingredients.

Notable affiliated individuals and investors include key figures in biotechnology and ophthalmology sectors, although specific names are not provided. Silk Technologies has achieved significant milestones in the commercialization of SDP products, gaining recognition for their innovative approach to ophthalmic care. Their impact is evident in the improved safety and efficacy of products within the ophthalmic market, contributing to better health outcomes for patients.

Silk Technologies - Similar Companies

Silk Therapeutics logo

Silk Therapeutics

Cocoon Biotech logo

Cocoon Biotech

cocoonbiotech.com

Evolved By Nature logo

Evolved By Nature

Selenium logo

Selenium

seleniumltd.com

SIL Technologies logo

SIL Technologies

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Thread Bioscience logo

Thread Bioscience

threadb.com

Neosil logo

Neosil

neosil.com

Stimusil logo

Stimusil

stimusil.com

InnSight Technology logo

InnSight Technology

innsightech.com

Bolt Projects Holdings logo

Bolt Projects Holdings

boltthreads.com

Sylvatica Biotech logo

Sylvatica Biotech

sylvaticabio.com

SiLC Technologies logo

SiLC Technologies

silc.com

Spheringenics logo

Spheringenics

Proteotech logo

Proteotech

Silk Technologies - Quick Facts

Who are Silk Technologies' competitors?

Companies similar to Silk Technologies include Silk Therapeutics, Cocoon Biotech, Evolved By Nature and Selenium.

When was Silk Technologies founded?

Silk Technologies was founded in 2013.

Where is Silk Technologies' headquarters located?

Silk Technologies' headquarters is located in Plymouth, MN, US.

When was Silk Technologies' last funding round?

Silk Technologies' most recent funding round was for $6.2M (USD) in April 2019.

How much has Silk Technologies raised to-date?

As of Apr 16, 2019, Silk Technologies has raised a total of $17.2M (USD).

How many employees does Silk Technologies have?

Silk Technologies has 30 employees as of Feb 5, 2024.

Silk Technologies - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Protein Products
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified